Skip to main content
. 2022 Jun 20;34(9):1949–1967. doi: 10.1007/s40520-022-02142-8

Table 3.

Frailty metabolic phenotypes

Anorexic malnourished (AM) Sarcopenic obese (S0)
Poor appetite, reduced energy intake and weight loss Good appetite, increased energy intake and weight gain
Reduced skeletal muscle mass and visceral fat Reduced skeletal muscle mass and increased visceral fat
Reduced insulin resistance Increased insulin resistance
Tendency to hypoglycaemia Tendency to hyperglycaemia
Diabetes course is regressive Diabetes course is progressive
Progressive deintensification of hypoglycaemic therapy Progressive intensification of hypoglycaemic agents
Weight limiting hypoglycaemic agents are not suitable Weight limiting hypoglycaemic agents are suitable